Well-absorbed curcumin for relief from occasional joint and muscle soreness*
Meriva-SF is a well-absorbed, sustained-released curcumin formula.* Meriva® is the most clinically studied curcumin on the market with 29x greater absorption than ordinary curcumin.*
Meriva® helps maintain a healthy inflammatory response throughout the body. Meriva-SF (sustained release) provides relief from occasional aches, joint stiffness, and muscle soreness.*
Used in Asia for thousands of years, curcumin is a potent antioxidant that offers multiple health benefits, including support of joint, liver, GI, eyes, and cardiovascular function.* Normally, however, curcumin is poorly absorbed in the bloodstream, whether it comes from food or nutritional supplements. Meriva curcumin phytosome, the most clinically studied curcumin on the market, is a unique curcumin extract with significantly better absorption than other curcumin extracts.* In fact, a human study demonstrated 29-times greater absorption for Meriva than with ordinary curcumin.*
Curcumin is an antioxidant flavonoid that helps maintain the body's normal inflammatory response through optimization of cytokine production.* Meriva's superior curcumin absorption is attributable to a unique formula that contains three curcuminoids (95% curcuminoid material) and is based on Indena S.p.A.'s proprietary "phytosome" technology. A phytosome is a plant extract bound to a phospholipid (from sunflower oil in the case of Meriva-SF). Phospholipids are essential components of all human cells; and although the body makes phospholipids, such as phosphatidylcholine and phosphatidylserine, phospholipids can also be obtained from food or nutritional supplements. When taken orally, phospholipids are very well absorbed. The proprietary phytosome technology utilized in Meriva-SF attaches a curcumin extract to a phospholipid, which optimizes the curcumin's absorption.* Meriva supplementation results in higher plasma concentrations of curcumin from a much smaller amount than with ordinary curcumin supplementation.*
Meriva-SF (sustained release) contains 250 mg of curcumin phytosome complex per capsule.
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.
If pregnant, consult your health professional before using this product.
Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research revealed that curcumin decreased camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided.